Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 4.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.26 | - |
NAV | ₹283.00 | - |
Fund Started | 01 Aug 2005 | - |
Fund Size | ₹1126.13 Cr | - |
Exit Load | Exit load of 1% if redeemed within 30 days. | - |
Risk
Very High
-
Rating
4.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.26
-
NAV
₹283.00
-
Fund Started
01 Aug 2005
-
Fund Size
₹1126.13 Cr
-
Exit Load
Exit load of 1% if redeemed within 30 days.
-
1 Year | -1.09% | - |
3 Year | 24.09% | - |
5 Year | 15.29% | - |
1 Year
-1.09%
-
3 Year
24.09%
-
5 Year
15.29%
-
Equity | 98.75% | - |
Cash | 1.24% | - |
Equity
98.75%
-
Cash
1.24%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.76% |
Ajanta Pharma Ltd. | 6.48% |
Lupin Ltd. | 5.91% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Dr. Reddy's Laboratories Ltd. | 3.74% |
Gland Pharma Ltd. | 3.46% |
Apollo Hospitals Enterprise Ltd. | 3.45% |
Alkem Laboratories Ltd. | 3.43% |
Procter & Gamble Health Ltd. | 3.41% |
Cipla Ltd. | 3.40% |
-
Name | Kamal Gada | - |
Start Date | 02 May 2022 | - |
Name
Kamal Gada
-
Start Date
02 May 2022
-
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | - |
Launch Date | 01 Aug 2005 | - |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
-
Launch Date
01 Aug 2005
-